| Multiplex genome engineering using CRISPR/Cas systems L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ... Science 339 (6121), 819-823, 2013 | 18329 | 2013 |
| RNA-guided editing of bacterial genomes using CRISPR-Cas systems W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini Nature biotechnology 31 (3), 233-239, 2013 | 3054 | 2013 |
| Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini Nucleic acids research 41 (15), 7429-7437, 2013 | 1402 | 2013 |
| Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ... Nature biotechnology 32 (11), 1146-1150, 2014 | 952 | 2014 |
| Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ... Cell 161 (5), 1164-1174, 2015 | 486 | 2015 |
| Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting GW Goldberg, W Jiang, D Bikard, LA Marraffini Nature 514 (7524), 633-637, 2014 | 306 | 2014 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 14/105,035, 2014 | 286 | 2014 |
| Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids W Jiang, I Maniv, F Arain, Y Wang, BR Levin, LA Marraffini PLoS genetics 9 (9), e1003844, 2013 | 253 | 2013 |
| CRISPR-Cas: new tools for genetic manipulations from bacterial immunity systems W Jiang, LA Marraffini Annual review of microbiology 69 (1), 209-228, 2015 | 243 | 2015 |
| Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity W Jiang, P Samai, LA Marraffini Cell 164 (4), 710-721, 2016 | 231 | 2016 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang US Patent App. 14/497,627, 2015 | 230 | 2015 |
| CRISPR-Cas component systems, methods and compositions for sequence manipulation F Zhang, DO BIKARD, L Cong, DBT Cox, P Hsu, W Jiang, LIN Shauiliang, ... | 224 | 2014 |
| CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity JW Modell, W Jiang, LA Marraffini Nature 544 (7648), 101-104, 2017 | 158 | 2017 |
| Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing SB Blattman, W Jiang, P Oikonomou, S Tavazoie Nature microbiology 5 (10), 1192-1201, 2020 | 151 | 2020 |
| A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs A Hatoum-Aslan, P Samai, I Maniv, W Jiang, LA Marraffini Journal of Biological Chemistry 288 (39), 27888-27897, 2013 | 135 | 2013 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana US Patent App. 15/887,377, 2018 | 131 | 2018 |
| CRISPR-assisted editing of bacterial genomes W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini Nature biotechnology 31 (3), 233, 2013 | 127 | 2013 |
| Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ... Nature biotechnology 32 (11), 1146, 2014 | 66 | 2014 |
| Impact of different target sequences on type III CRISPR-Cas immunity I Maniv, W Jiang, D Bikard, LA Marraffini Journal of bacteriology 198 (6), 941-950, 2016 | 56 | 2016 |
| Comprehensive genome-wide perturbations via CRISPR adaptation reveal complex genetics of antibiotic sensitivity W Jiang, P Oikonomou, S Tavazoie Cell 180 (5), 1002-1017. e31, 2020 | 45 | 2020 |
